Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Query: "TILT[LastUpdatePostDate]SEARCH[Study]AREA[SponsorSearch]Shenyang Sunshine Pharmaceutical Co., LTD."
Count: 18
Selected: 0
NCT IDTitle
NCT05211167Phase III Clinical Study of Recombinant Erythropoiesis Stimulating Protein Injection (rESP) in the Treatment of Anemia in Hemodialysis Patients With Chronic Renal Failure
NCT05193201A Phase Ib Clinical Study for rhTPO in the Treatment of Thrombocytopenia in Patients With Chronic Liver Disease
NCT04893187A Phase 1 Study of SSS17 in Healthy Subjects.
NCT04047394A Study to Determine the Safety, Tolerability, PK and Preliminary PD of SSS11 in Chinese Healthy Adult Volunteers
NCT04728984A Multi-site Bridging Study of Nalfurafine Hydrochloride Orally Disintegrating Tablet
NCT02947438Biosimilar Erythropoietin in Anaemia Treatment (Maintenance Phase Study)
NCT02522975Biosimilar Erythropoietin in Anaemia Treatment (Correction Phase Study)
NCT04317833A Study of SSS17 in Healthy Subjects
NCT03673215The Tolerability,Safety,PK/PD Study of rhTPO in the Patients With Liver Function Impairment
NCT03950687Study of rESP Injection for the Treatment of Anemia in Chronic Renal Failure Patients With Hemodialysis
NCT04089267Evaluating the Efficacy and Safety of Different Human Thrombopoietin (rhTPO) Regimens in the Treatment of Patients With Primary Immune Thrombocytopenia (ITP)
NCT03388515A Study to Assess the Safety and Tolerability of SSS11 in Healthy Subjects.
NCT02460393A Trial With Humanized TNFα Monoclonal Antibody Injection by Single Dose and Dose Escalation in Healthy Subjects
NCT02356419rESP Medication With a Single Intravenous Administration and Dose Escalation to Explore the Tolerability ,Safety and Pharmacokinetic Characteristics
NCT02344979The Study of rHuTPO/rHuIL-11 in the Treatment for Chemotherapy-induced Thrombocytopenia in Patients With NSCLC
NCT05411705Efficacy and Safety of rhTPO's Prophylactic Treatment of CTIT in Patients With High Risk of Cardiac Injury
NCT04420234A Pharmacokinetics and Safety Study of Narfurine Hydrochloride Orally Disintegrating Tablets
NCT01805648Efficacy and Safety Study of Maintenance Treatment With rhTPO in Thrombocytopenic Subjects With ITP